June 07, 2026 — RNews

#steatosis — Sunday, June 07, 2026 (1 items)

hot top new

← prev day next day →

0

Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial. (nature.com)

Kaplan LM … Sanyal AJ Nature Medicine 2026-06-07

#metabolism #clinical trial #obesity #fibrosis #steatosis